49 results on '"Rossini, Silvano"'
Search Results
2. Is SARS-CoV-2 screening still necessary before hematopoietic stem cell donation? Observations from a single center and review of the literature
Catalog
Books, media, physical & digital resources
3. Potential selection of unrelated donor based on HLA-DPB1 T-cell epitope matching using data from a single-center analysis
4. Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine
5. SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility
6. Results of the RENAISSANCE Study: REsponse to BNT162b2 COVID-19 vacciNe—short- And long-term Immune reSponSe evAluatioN in health Care workErs
7. New‐Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine‐Induced Thrombotic Thrombocytopenia
8. Correlation analysis between virtual and Complement-Dependent-Cytotoxicity crossmatch in a monocenter retrospective series of 118 allografted patients
9. Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
10. Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
11. Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection
12. The number of HLA confirmatory tests during unrelated donor search as a driver for the evaluation of back-up haploidentical donor(s)
13. Clinical Utility of Fractionating Erythrocytes into “Percoll” Density Gradients
14. A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry
15. Flow cytometry analysis of lymphocyte subsets in bronchoalveolar lavage: comparison between lung non-Hodgkin lymphomas and reactive diseases
16. Clinical relevance of antiplatelet antibodies and the hepatic clearance of platelets in patients with immune thrombocytopenia
17. Response of steroid‐refractory chronic graft‐versus‐host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles
18. Loss of Suppressor-inducer T-Cells in Chronic-progressive Multiple Sclerosis: Preliminary Results
19. Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes
20. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study
21. Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
22. The Challenge Of HSCs Procurement For Gene Therapy: Exploring Plerixafor As Mobilization Agent
23. Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes
24. Plerixafor Single Agent for Autologous Stem Cells Mobilization and Collection in Adult Thalassemic Patients: Towards the Assessment of the Suitable Hematopoietic Stem Cell Source for Gene Therapy of Beta-Thalassemia.
25. Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation
26. Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients.
27. Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors.
28. Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
29. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
30. Genomic Loss of the Mismatched HLA Locus in Leukemia Is a Major Mechanism of in Vivo Escape from T Cell Immunosurveillance Following Haploidentical HSCT
31. Temporal, quantitative, and functional characteristics of single-KIR–positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation
32. Chlamydophila psittaciis viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: Results of a single‐center prospective case–control study
33. Frequency and Targeted Detection of HLA-DPB1 T Cell Epitope Disparities Relevant in Unrelated Hematopoietic Stem Cell Transplantation
34. Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation
35. Impaired GvL Potential of Natural Killer Cells Early Reconstituting Following Haploidentical HSCT.
36. Epitope-Specific Typing (EST) for HLA-DPB1 Matching: Proof of Principle for an Innovative Approach to Unrelated Hematopoietic Stem Cell Donor Selection.
37. Therapeutic and Diagnostic Applications of Minor Histocompatibility Antigen HA-1 and HA-2 Disparities in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey of Different Populations
38. Receptor Repertoire Reconstitution Suggests Acquisition of Patient-Specific Tolerance by Natural Killer Cells Arising from Hematopoietic Progenitor Stem Cells after Haploidentical Transplantation.
39. Selective intra-graft apoptosis and down-regulation of lymphocyte bcl-2, iNOs and CD95L expression in kidney-pancreas transplanted patients after anti-Thymoglobulin induction
40. Selective intra-graft apoptosis and down-regulation of lymphocyte bcl-2, iNOs and CD95L expression in kidney?pancreas transplanted patients after anti-Thymoglobulin induction
41. Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells
42. Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells
43. HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
44. Transfer of the HSV-tk Gene into Donor Peripheral Blood Lymphocytes for In Vivo Modulation of Donor Anti-Tumor Immunity after Allogeneic Bone Marrow Transplantation. The San Raffaele Hospital, Milan, Italy
45. Expression and modulation of a mononuclear phagocyte differentiation antigen (PAM-1) during in vitro maturation of peripheral blood monocytes
46. Transfer of the ADA Gene into Bone Marrow Cells and Peripheral Blood Lymphocytes for the Treatment of Patients Affected by ADA-Deficient SCID
47. An in Vivo Model of Somatic Cell Gene Therapy for Human Severe Combined Immunodeficiency
48. Immunological and genotypic analysis of human Tγ-lymphoproliferative disorders
49. Skin Involvement in Hemopathies: Specific Cutaneous Manifestations of Acute Nonlymphoid Leukemias and Non-Hodgkin Lymphomas
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.